Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby br…
Drug Manufacturers - General
US, New Brunswick [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Johnson & Johnson (JNJ) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 97,121.26 | 36,085.94 | 3,226.17 | 11,859.19 | -3,951.56 | 0.01 | -4.3065 | 63.97 | 0.5869 | 0.0121 | 0.00 | 0.07 | 2.2739 | - - | ||
| Maximum | - - | - - | - - | 854,616.00 | 515,874.00 | 44,471.00 | 133,091.00 | 1,294.00 | 0.04 | 46.2856 | 1,087.57 | 1.0000 | 0.2203 | 0.03 | 0.53 | 21.1421 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 77.00 | -82.00 | -1,283.00 | -63,834.00 | 0.00 | -311.9276 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AbbVie Inc. ABBV | 176.95 | 5.22 3.04% | 7,841 vs. 5,489 | 312,695.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| Gilead Sciences, Inc. GILD | 90.19 | 0.43 0.48% | 4,427 vs. 6,704 | 112,401.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 58.87 | 0.64 1.10% | 7,369 vs. 11,013 | 119,398.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.65 | 0.52 2.07% | 41,844 vs. 36,852 | 145,358.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 294.53 | 4.63 1.60% | 2,851 vs. 2,190 | 158,319.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Eli Lilly and Company LLY | 748.01 | -1.91 -0.25% | 2,778 vs. 3,411 | 710,097.00 | 8,768.00 | 2,242.00 | 179.00 | 12,553.00 | 2.4900 | 76.3636 | 0.0017 | 0.8250 | 0.2558 | 0.1751 | 0.0351 | 0.6775 | 949.00 | ||
| Merck & Co., Inc. MRK | 99.18 | -0.68 -0.68% | 14,028 vs. 9,812 | 250,889.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 155.17 | -0.33 -0.21% | 5,561 vs. 6,399 | 373,590.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.